Table 2.
Descriptive report of different treatment regimens’ effect on COVID-19 transplant patients' outcome
| Drugs | Length of stay; mean ± SEM* | O2 therapy (%) | Mortality (%) | |||
|---|---|---|---|---|---|---|
| Intensive care unit stay | Hospital | Mechanical ventilation used | Mechanical ventilation not used | Yes | No | |
| Hydroxychloroquine | ||||||
| No | 16.22 ± 9.87 | 27.21 ± 15.32 | 11 (19) | 155 (83) | 8 (40) | 158 (70) |
| Yes | 20.98 ± 10.09 | 30.87 ± 15 | 48 (81) | 31 (17) | 12 (60) | 67 (30) |
| Interferon | ||||||
| No | 17.70 ± 15.44 | 26.59 ± 13.90 | 49 (83) | 41 (48) | 11 (55) | 79 (35) |
| Yes | 22.88 ± 16.79 | 31.11 ± 14.00 | 10 (17) | 45 (52) | 9 (45) | 46 (20) |
| Lopinavir/Ritonavir | ||||||
| No | 20.19 + 16.60 | 24.40 ± 14.00 | 15 (25) | 40 (47) | 1 (5) | 54 (24) |
| Yes | 27.60 ± 15.43 | 34.30 ± 16.99 | 44 (75) | 46 (53) | 19 (95) | 71 (32) |
| Remdesivir | ||||||
| No | 24.31 ± 12.41 | 34.45 ± 13.76 | 46 (78) | 97 (52) | 10 (50) | 133 (59) |
| Yes | 18.91 ± 10.00 | 27.00 ± 11.65 | 13 (22) | 89 (48) | 10 (50) | 92 (41) |
| Tocilizumab | ||||||
| No | 23.30 ± 13.13 | 31.11 ± 12.00 | 49 (82) | 136 (74) | 13 (65) | 172 (76) |
| Yes | 18.83 ± 10.90 | 28.00 ± 14.10 | 11 (18) | 49 (26) | 7 (35) | 53 (24) |
| Dexamethasone or High dose methylprednisolone | ||||||
| No | 24.33 ± 13.00 | 33.30 ± 13.00 | 45 (76) | 64 (34) | 9 (45) | 100 (44) |
| Yes | 19.77 ± 12.00 | 29.70 ± 11.10 | 14 (24) | 122 (66) | 11 (55) | 125 (56) |
*Standard error of the mean